RASA is an early-stage company with the focus on developing life-science-based technologies interfacing with biomaterials, tumor biology and nanotechnology. In order to address the current challenges in the medicine and biology with engineering solutions, we founded RASA to have a breakthrough in developing low cost, smart and customizable technologies. Our main product under development is a bioengineered solution for high-throughput in-vitro tumor modeling and related anti-cancer therapeutic screening. In this technology we deliver the potential of 3D cell culture merged with nano-biosensors to the preclinical tumor studies for early and real time drug screening.